Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
15,096,238
-
Shares change
-
-117,061
-
Total reported value, excl. options
-
$43,780,064
-
Value change
-
-$552,911
-
Number of buys
-
37
-
Number of sells
-
-30
-
Price
-
$2.9
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2016
88 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q4 2016.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,096,238 shares
of 22,163,711 outstanding shares and own 68.11% of the company stock.
Largest 10 shareholders include FMR LLC (3,706,402 shares), Numeric Investors LLC (1,235,345 shares), VHCP Management, LLC (1,102,735 shares), RENAISSANCE TECHNOLOGIES LLC (969,700 shares), EcoR1 Capital, LLC (874,447 shares), BlackRock Fund Advisors (758,714 shares), VANGUARD GROUP INC (485,779 shares), BlackRock Institutional Trust Company, N.A. (478,837 shares), PRIMECAP MANAGEMENT CO/CA/ (425,600 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (363,400 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.